国产9精品9,人妻熟妇精品,久久成人在线第一页

BMS's Q1 2025 Financial report Market Trend Bristol Myers Squibb Q1 2025 earnings: revenue down 6% YoY, but strong product performance drives EPS growth. Full-year guidance raised. Highlights include Opdivo, Reblozyl, and Breyanzi.
2024 Global CAR-T Sales Performance CAR-T Discover the sales performance of CAR-T therapies in 2024, including Kymriah, Yescarta, Breyanzi, and more. Explore trends, growth, and challenges in the CAR-T cell therapy market across the US and beyond.
Pharmaceutical Giants Ranking 2024 Market Trend Explore the top pharmaceutical giants of 2024, including Merck, Johnson & Johnson, and more. Learn about their revenue, profits, R&D investments, and market value in this detailed ranking report.
BMS 2024 Annual Report Financial statements BMS reported a 7% increase in 2024 revenue to $48.3B, driven by strong growth from Eliquis and Camzyos. The company projects a decline in legacy product sales in 2025 but plans to save $2B in costs by 2027.
Top 10 Immunology Drugs to Watch in 2024 AbbVie Explore the top 10 best-selling immunology drugs of 2023, including Humira, Dupixent, Stelara, and more. Discover how these innovative therapies are shaping the market, driving clinical breakthroughs, and overcoming competitive challenges.
November Biopharmaceutical Company Layoff Summary Layoff November 2024 saw significant layoffs in the biopharma industry, with 20 companies announcing cuts due to economic pressures, failed projects, and restructuring. Key layoffs include major firms like 23andMe, Novartis, and Bristol Myers Squibb.
"Old Money" BMS, Eager to Earn New Money Bristol Myers Squibb Bristol Myers Squibb (BMS) is striving to break its slump with FDA approval of its schizophrenia drug Kar-XT, marking a critical turning point. With forecasted sales of $3.1 billion by 2030, BMS aims to rebound despite recent challenges, including layoffs and patent cliffs.
Bristol Myers Squibb's First-Quarter 2024 Financial statements Financial statements Bristol Myers Squibb published its Q1 2024 financial statements on April 25, 2024.

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

国产91视频久久,亚洲综合色图在线观看,五月天操逼网,日韩色色AV,青青在线A片,亚洲最大色在线观看,欧美熟妇丝袜诱惑,青青操逼视频,日韩无码操出水